Exosome therapy shows promise for liver crisis in small trial
NCT ID NCT07409259
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether exosomes (tiny particles from stem cells) can help people with sudden severe liver failure. Twenty adults will receive either standard care alone or standard care plus four doses of exosomes over 10 days. The main goal is to check safety and see if the treatment improves survival at 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Third Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China 510630
Guangzhou, Guangdong, 510630, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Better crystal ball for liver crisis: new scores put to the test
- New liver support protocol could help patients avoid transplant
- Pig liver trial offers temporary lifeline for liver failure patients
- New liver dialysis machine could save lives in severe liver failure
- Stem cell injection aims to prevent deadly liver complication
- Can vitamin c save kidneys in liver failure patients?